MicroRNA-26a targets the mdm2/p53 loop directly in response to liver regeneration

Zhou,Jian; Li,Zhuoyuan; Huang,Yingbin; Ju,Weiqiang; Wang,Dongping; Zhu,Xiaofeng; He,Xiaoshun

doi:10.3892/ijmm.2019.4282

MicroRNA-26a targets the mdm2/p53 loop directly in response to liver regeneration

Authors:
- Jian Zhou
- Zhuoyuan Li
- Yingbin Huang
- Weiqiang Ju
- Dongping Wang
- Xiaofeng Zhu
- Xiaoshun He
View Affiliations

Affiliations: Organ Transplant Centre, The First Affiliated Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 510080, P.R. China
Published online on: July 22, 2019 https://doi.org/10.3892/ijmm.2019.4282
Pages: 1505-1514

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Liver regeneration (LR) is the result of a dynamic balance between the increased proliferation and decreased apoptosis of hepatocytes. However, the role of microRNA (miR)‑26a in regulating complex signalling networks involving E3 ubiquitin‑protein ligase Mdm2 (mdm2), p53, p21 and p27 in the process of LR is currently unclear. In the present study, it was hypothesized that miR‑26a may negatively regulate the mdm2/p53 signalling loop in response to LR. In vitro experiments were performed, whereby mouse liver cells were transfected with an miR‑26a vector or an anti/miR‑26a vector. Cell proliferation was analysed using an MTS assay and cell apoptosis, and cell cycle progression were analysed by flow cytometry. In addition, the expression of mdm2, p53, p21 and p27 were assessed using western blotting and reverse transcription‑quantitative polymerase chain reaction analyses. Dual‑luciferase reporter assays were also used to examine the association between mdm2 and miR‑26a. A 70% partial hepatectomy in C57BL/6J mice was then performed, which was followed by injection with an mdm2‑cDNA vector or an mdm2‑small interfering RNA vector. The liver‑to‑body weight ratio and liver function of mice were measured at 72 h following vector administration. The results demonstrated an increase in hepatocyte proliferation accompanied by decreased hepatocyte apoptosis levels. In addition, inhibition of miR‑26a expression was associated with a marked increase in mdm2 expression, while the expression of p53, p21 and p27 was decreased when compared with negative controls. The opposite effects were observed when miR‑26a was overexpressed. Notably, miR‑26a was demonstrated to target the 3'‑untranslated region of mdm2 directly. The results of the present study are the first to demonstrate as far as the authors are aware that the mdm2/p53 negative feedback loop may be targeted by miR‑26a directly in response to LR, and that mdm2 negatively regulates p53, p21 and p27 but not miR‑26a. miR‑26a may therefore function as an important factor that regulates the interaction between mdm2 and p53.

View Figures

View References

1	Port JD and Sucharov C: Role of microRNAs in cardiovascular disease: Therapeutic challenges and potentials. J Cardiovasc Pharmacol. 56:444–453. 2010. View Article : Google Scholar : PubMed/NCBI
2	Lynn FC: Meta-regulation: MicroRNA regulation of glucose and lipid metabolism. Trends Endocrinol Metab. 20:452–459. 2009. View Article : Google Scholar : PubMed/NCBI
3	Pager CT, Wehner KA, Fuchs G and Sarnow P: MicroRNA-mediated gene silencing. Prog Mol Biol Transl Sci. 90:187–210. 2009. View Article : Google Scholar : PubMed/NCBI
4	Hammond SM: MicroRNA therapeutics: A new niche for antisense nucleic acids. Trends Mol Med. 12:99–101. 2006. View Article : Google Scholar : PubMed/NCBI
5	He L and Hannon GJ: MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004. View Article : Google Scholar : PubMed/NCBI
6	Zhou J, Ju QW, Yuan XP, Zhu XF, Wang DP and He XS: miR-26a regulates mouse hepatocyte proliferation via directly targeting their 3′untranslated region of CCND2 and CCNE2. Hepatobiliary Pancreat Dis Int. 15:65–72. 2016. View Article : Google Scholar : PubMed/NCBI
7	Zhou J, Ju W, Wang D, Wu L, Zhu X, Guo Z and He X: Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration. PLoS One. 7:e335772012. View Article : Google Scholar : PubMed/NCBI
8	Momand J, Zambetti GP, Olson DC, George D and Levine AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell. 69:1237–1245. 1992. View Article : Google Scholar : PubMed/NCBI
9	Haupt Y, Maya R, Kazaz A and Oren M: Mdm2 promotes the rapid degradation of p53. Nature. 387:296–299. 1997. View Article : Google Scholar : PubMed/NCBI
10	Eischen CM and Lozano G: p53 and MDM2: Antagonists or partners in crime? Cancer Cell. 15:161–162. 2009. View Article : Google Scholar : PubMed/NCBI
11	Barak Y, Juven T, Haffner R and Oren M: Mdm2 expression is induced by wild-type p53 activity. EMBO J. 12:461–468. 1993. View Article : Google Scholar : PubMed/NCBI
12	Harris SL and Levine AJ: The p53 pathway: Positive and negative feedback loops. Oncogene. 24:2899–2908. 2005. View Article : Google Scholar : PubMed/NCBI
13	Cao LQ, Wang YN, Liang M and Pan MZ: CALB1 enhances the interaction between p53 and MDM2, and inhibits the senescence of ovarian cancer cells. Mol Med Rep. 19:5097–5104. 2019.PubMed/NCBI
14	Xu X, Liu Q, Zhang C, Ren S, Xu L, Zhao Z, Dou H, Li P, Zhang X, Gong Y and Shao C: Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence. Cell Death Dis. 10:2822019. View Article : Google Scholar : PubMed/NCBI
15	Wurz RP and Cee VJ: Targeted degradation of MDM2 as a new approach to improve the efficacy of MDM2-p53 inhibitors. J Med Chem. 62:445–447. 2019. View Article : Google Scholar
16	Shunchang S, Haitao C, Weidong C, Jingbo H and Yunsheng P: Expression of truncated dystrophin cDNAs mediated by a lentiviral vector. Neurol India. 56:52–56. 2008. View Article : Google Scholar : PubMed/NCBI
17	Guo J, Li M, Meng X, Sui J, Dou L, Tang W, Huang X, Man Y, Wang S and Li J: miR-291b-3p induces apoptosis in liver cell line NCTC1469 by reducing the level of RNA-binding protein HuR. Cell Physiol Biochem. 33:810–822. 2014. View Article : Google Scholar : PubMed/NCBI
18	Mitchell C and Willenbring H: A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc. 3:1167–1170. 2008. View Article : Google Scholar : PubMed/NCBI
19	Bockhorn M, Goralski M, Prokofiev D, Dammann P, Grünewald P, Trippler M, Biglarnia A, Kamler M, Niehues EM, Frilling A, et al: VEGF is important for early liver regeneration after partial hepatectomy. J Surg Res. 138:291–299. 2007. View Article : Google Scholar : PubMed/NCBI
20	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
21	Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP and Bartel DP: MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol Cell. 27:91–105. 2007. View Article : Google Scholar : PubMed/NCBI
22	Betel D, Wilson M, Gabow A, Marks DS and Sander C: The microRNA.org resource: Targets and expression. Nucleic Acids Res. 36(Database issue): D149–D153. 2008. View Article : Google Scholar :
23	Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M and Rajewsky N: Combinatorial microRNA target predictions. Nat Genet. 37:495–500. 2005. View Article : Google Scholar : PubMed/NCBI
24	Zhang J, Sun Q, Zhang Z, Ge S, Han ZG and Chen WT: Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene. 32:61–69. 2013. View Article : Google Scholar
25	Suh SS, Yoo JY, Nuovo GJ, Jeon YJ, Kim S, Lee TJ, Kim T, Bakàcs A, Alder H, Kaur B, et al: MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proc Natl Acad Sci USA. 109:5316–5321. 2012. View Article : Google Scholar : PubMed/NCBI
26	Xiao J, Lin H, Luo X and Wang Z: miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress. EMBO J. 30:524–532. 2011. View Article : Google Scholar : PubMed/NCBI
27	Cahilly-Snyder L, Yang-Feng T, Francke U and George DL: Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat Cell Mol Genet. 13:235–244. 1987. View Article : Google Scholar : PubMed/NCBI
28	Chen J, Wu X, Lin J and Levine AJ: Mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol Cell Biol. 16:2445–2452. 1996. View Article : Google Scholar : PubMed/NCBI
29	Brown DR, Thomas CA and Deb SP: The human onco-protein MDM2 arrests the cell cycle: Elimination of its cell-cycle-inhibitory function induces tumorigenesis. EMBO J. 17:2513–2525. 1998. View Article : Google Scholar : PubMed/NCBI
30	Dang J, Kuo ML, Eischen CM, Stepanova L, Sherr CJ and Roussel MF: The RING domain of Mdm2 can inhibit cell proliferation. Cancer Res. 62:1222–1230. 2002.PubMed/NCBI
31	Wade M, Wang YV and Wahl GM: The p53 orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol. 20:299–309. 2010. View Article : Google Scholar : PubMed/NCBI
32	Kruse JP and Gu W: Modes of p53 regulation. Cell. 137:609–622. 2009. View Article : Google Scholar : PubMed/NCBI
33	Juven T, Barak Y, Zauberman A, George DL and Oren M: Wild-type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene. 8:3411–3416. 1993.PubMed/NCBI
34	Wu X, Bayle JH, Olson D and Levine AJ: The p53-mdm-2 auto-regulatory feedback loop. Genes Dev. 7:1126–1132. 1993. View Article : Google Scholar : PubMed/NCBI
35	Phillips A, Teunisse A, Lam S, Lodder K, Darley M, Emaduddin M, Wolf A, Richter J, de Lange J, Verlaan-de Vries M, et al: HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity. J Biol Chem. 285:29111–29127. 2010. View Article : Google Scholar : PubMed/NCBI
36	Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B: Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature. 362:857–860. 1993. View Article : Google Scholar : PubMed/NCBI
37	Chen J, Lin J and Levine AJ: Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol Med. 1:142–152. 1995. View Article : Google Scholar : PubMed/NCBI
38	Vousden KH and Lu X: Live or let die: The cell's response to p53. Nat Rev Cancer. 2:594–604. 2002. View Article : Google Scholar : PubMed/NCBI
39	Vousden KH and Ryan KM: p53 and metabolism. Nat Rev Cancer. 9:691–700. 2009. View Article : Google Scholar : PubMed/NCBI
40	Lane DP: Cancer. p53, guardian of the genome. Nature. 358:15–16. 1992. View Article : Google Scholar : PubMed/NCBI
41	Soussi T and Béroud C: Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer. 1:233–240. 2001. View Article : Google Scholar
42	Hollstein M, Sidransky D, Vogelstein B and Harris CC: p53 mutations in human cancers. Science. 253:49–53. 1991. View Article : Google Scholar : PubMed/NCBI
43	Deng J, Yang M, Jiang R, An N, Wang X and Liu B: Long non-coding RNA HOTAIR regulates the proliferation, self-renewal capacity, tumor formation and migration of the cancer stem-like cell (CSC) subpopulation enriched from breast cancer cells. PLoS One. 12:e01708602017. View Article : Google Scholar : PubMed/NCBI
44	Nakae J, Kitamura T, Kitamura Y, Biggs WH III, Arden KC and Accili D: The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell. 4:119–129. 2003. View Article : Google Scholar : PubMed/NCBI
45	Dijkers PF, Medema RH, Pals C, Banerji L, Thomas NS, Lam EW, Burgering BM, Raaijmakers JA, Lammers JW, Koenderman L and Coffer PJ: Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol. 20:9138–9148. 2000. View Article : Google Scholar : PubMed/NCBI
46	Ezhilarasan D, Evraerts J, Sid B, Calderon PB, Karthikeyan S, Sokal E and Najimi M: Silibinin induces hepatic stellate cell cycle arrest via enhancingp53/p27 and inhibiting Akt downstream signaling protein expression. Hepatobiliary Pancreat Dis Int. 16:80–87. 2017. View Article : Google Scholar : PubMed/NCBI
47	Gartel AL and Radhakrishnan SK: Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 65:3980–3985. 2005. View Article : Google Scholar : PubMed/NCBI
48	Hofseth LJ, Hussain SP and Harris CC: p53: 25 years after its discovery. Trends Pharmacol Sci. 25:177–181. 2004. View Article : Google Scholar : PubMed/NCBI
49	Saile B, Matthes N, El Armouche H, Neubauer K and Ramadori G: The bcl, NFkappaB and p53/p21WAF1 systems are involved in spontaneous apoptosis and in the anti-apoptotic effect of TGF-beta or TNF-alpha on activated hepatic stellate cells. Eur J Cell Biol. 80:554–561. 2001. View Article : Google Scholar : PubMed/NCBI